OCP vs Metformin on Ovarian Stromal Blood Flow in PCOS
Launched by S.C.B. MEDICAL COLLEGE AND HOSPITAL · Jul 29, 2017
Trial Information
Current as of June 25, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Women diagnosed with PCOS according to the Rotterdam criteria
- Exclusion Criteria:
- • Current or previous use of oral contraceptives, glucocorticoids, antiandrogens, ovulation induction agents, antidiabetic and anti-obesity drugs or other hormonal drugs.
- • Medical or surgical treatment of PCOS during the previous 3 months
- • Presence of other endocrinopathies; except treated hypothyroidism on stable replacement doses of thyroid hormone
- • Pregnancy, breastfeeding or desire for pregnancy during study interval (6 months)
- • Inability to understand the proposal of the study precluding effective informed consent
About S.C.B. Medical College And Hospital
s.c.b. Medical College and Hospital is a renowned medical institution dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence in patient care, education, and research, the institution actively participates in clinical trials aimed at improving medical treatments and outcomes. Its multidisciplinary team of experienced professionals collaborates with regulatory bodies and industry partners to ensure the highest standards of ethical practice and scientific rigor. By fostering a culture of inquiry and collaboration, s.c.b. Medical College and Hospital plays a pivotal role in contributing to the advancement of medical knowledge and improving health outcomes in the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cuttack, Orissa, India
Patients applied
Trial Officials
Priyadarshini Tripathy, MD
Principal Investigator
SCB Medical College
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials